DIABETES Targeting VEGF-B as a Novel Treatment for Insulin Resistance and Type 2 Diabetes Scientists showed that decreased vascular endothelial growth factor B (VEGF-B) signaling in rodent models of type 2 diabetes restores insulin sensitivity and improves glucose tolerance. Pharmacological inhibition of VEGF-B signaling by antibody administration to db/db mice enhanced glucose tolerance, preserved pancreatic islet architecture, improved ß-cell function and ameliorated dyslipidemia, key elements of type 2 diabetes and the metabolic syndrome. [Nature] Abstract | Press Release Inhibition of Activin/Nodal Signaling Is Necessary for Pancreatic Differentiation of Human Pluripotent Stem Cells Scientists used defined culture media to identify signaling pathways controlling the differentiation of human embryonic stem cells and human induced pluripotent stem cells into pancreatic or hepatic progenitors. The study revealed that activin/TGF-β signaling blocks pancreatic specification induced by retinoic acid while promoting hepatic specification in combination with bone morphogenetic protein and fibroblast growth factor. [Diabetologia] Abstract Deficiency in the Nuclear Factor E2-Related Factor 2 Renders Pancreatic β-Cells Vulnerable to Arsenic-Induced Cell Damage Investigators found that MIN6 pancreatic β-cells with stable knockdown of nuclear factor E2-related factor 2 (Nrf2) by lentiviral shRNA and pancreatic islets isolated from Nrf2-knockout mice exhibited reduced expression of several antioxidant and detoxification enzymes in response to acute inorganic arsenite exposure. [Toxicol Appl Pharmacol] Abstract Activation of Transmembrane Bile Acid Receptor TGR5 Stimulates Insulin Secretion in Pancreatic β Cells Researchers demonstrated that the TGR5 expressed in the pancreatic β cells regulates insulin secretion and highlights the importance of ongoing therapeutic strategies targeting TGR5 in the control of glucose homeostasis. [Biochem Biophys Res Commun] Abstract PANCREATIC CANCER Novel Involvement of Leukotriene B4 Receptor 2 through ERK Activation by PP2A Down-Regulation in Leukotriene B4-Induced Keratin Phosphorylation and Reorganization of Pancreatic Cancer Cells Results suggested that leukotriene B4 receptor 2 is involved in leukotriene B4-induced phosphorylation and reorganization through ERK activation by protein phosphatase 2A (PP2A) downregulation, leading to increased migration of PANC-1 cells. [Biochim Biophys Acta] Abstract S100P Is a Metastasis-Associated Gene that Facilitates Transendothelial Migration of Pancreatic Cancer Cells Investigators showed that S100P increases the transendothelial migration of pancreatic ductal adenocarcinoma cancer cells in vitro, which was also confirmed in vivo experiments using a zebrafish embryo model. Therefore, S100P facilitates cancer cell intravasation/extravasation, which are critical steps in the hematogenous dissemination of pancreatic cancer cells. [Clin Exp Metastasis] Abstract Involvement of Annexin A8 in the Properties of Pancreatic Cancer Researchers investigated the molecular mechanism of expression of Annexin A8 in cancer cells and its functional role in pancreatic cancer cells. [Mol Carcinog] Abstract Mechanistic Studies of Gemcitabine-Loaded Nanoplatforms in Resistant Pancreatic Cancer Cells Gemcitabine was encapsulated in two types of commonly used nanovectors and their physico-chemical parameters were assessed in vitro. Their mechanisms of action in human pancreatic cells were compared with those of the free drug, and with each other’s, using cytotoxity, apoptosis and ultrastructural analyses. [BMC Cancer] Abstract | Full Article Synergistic Effects of Photodynamic Therapy with HPPH and Gemcitabine in Pancreatic Cancer Cell Lines Photodynamic therapy (PDT) is a potential treatment for pancreatic cancer. The authors investigated the efficacy of PDT with 2-[1-hexyloxyethyl]-2-devinyl pyropheophorbide (HPPH) and gemcitabine in inducing cell death in multiple pancreatic cancer cell lines. [Lasers Surg Med] Abstract
|